In addition, BRG1 is upregulated with little evidence of mutation in primary breast and prostate tumors, in melanoma and neuroblastoma, and in pancreatic, gastric, and colorectal carcinomas [22, 23, 60–67]. This evidence concerns the gene SMARCA4 and prostate neoplasm.